Enhanced External Counterpulsation (EECP) therapy is a non-invasive treatment that helps improve blood flow to the heart and relieve symptoms of angina and heart failure.

EECP therapy uses inflatable cuffs wrapped around the legs to compress and decompress the blood vessels, promoting increased blood flow to the heart during the relaxation phase of the heartbeat.

Patients with chronic stable angina, heart failure, or those who are not suitable candidates for invasive procedures like angioplasty or bypass surgery may benefit from EECP therapy.

EECP therapy can help reduce angina symptoms, improve exercise tolerance, enhance the quality of life, and decrease the need for medication in some patients.

Each EECP session typically lasts about one hour and is usually conducted five days a week for a total of seven weeks.

Risks include infection, bleeding, implant malfunction, and changes in penile sensation or function.

Dengue fever is a mosquito-borne viral infection causing flu-like symptoms, and in severe cases, it can lead to dengue hemorrhagic fever or dengue shock syndrome.

Anyone experiencing symptoms of dengue fever, particularly within the first few days of illness, should consider this test for early diagnosis.

Yes, the Dengue NS1 Antigen Test is highly accurate in detecting early dengue infection, especially within the first five days of symptom onset.

The test involves a blood draw, which is then analyzed in a laboratory to detect the NS1 antigen.

A positive result indicates a dengue infection. Your healthcare provider will discuss treatment options and may recommend further testing or monitoring.